SCHEMBL8320265

SCHEMBL8320265

O=C(c1cc2ncnc(NC(CO)c3nc4cc(Cl)ccc4[nH]3)c2cc1Cl)N1CC=CC1

nearest known ligand 0.34

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
RPS6KB1 P23443 2/20 0.33
AKT1 P31749 2/20 0.33
AURKB Q96GD4 1/20 0.33
INCENP Q9NQS7 1/20 0.33
AURKA O14965 2/20 0.33
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.32
HRH4 Q9H3N8 1/20 0.32
ROCK2 O75116 1/20 0.32
CNR1 P21554 4/20 0.32
TRPV1 Q8NER1 2/20 0.32
CDK1 P06493 2/20 0.32
MAPK8 P45983 2/20 0.32
MAPK10 P53779 2/20 0.32
CNR2 P34972 1/20 0.32
OPRM1 P35372 1/20 0.32
OPRD1 P41143 1/20 0.32
CTDSP1 Q9GZU7 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13772294 1.00 RPS6KB1 (0.33) RPS6KB1AKT1AURKBINCENPAURKA
SCHEMBL3000212 1.00 RPS6KB1 (0.33) RPS6KB1AKT1AURKBINCENPAURKA
SCHEMBL6223797 0.94 CYP1A2 (0.38) RPS6KB1AKT1AURKBINCENPAURKA
SCHEMBL4141467 0.91 ALDH1A1 (0.37) ALDH1A1LMNAHRH4ROCK2CDK1
SCHEMBL3003700 0.91 EGFR (0.35) RPS6KB1AURKAALDH1A1LMNAHRH4
SCHEMBL8323127 0.91 ALDH1A1 (0.37) ALDH1A1LMNAHRH4ROCK2CDK1
SCHEMBL4162062 0.91 AURKA (0.33) RPS6KB1AKT1AURKBINCENPAURKA
SCHEMBL4141464 0.91 ALDH1A1 (0.37) ALDH1A1LMNAHRH4ROCK2CDK1
SCHEMBL8317288 0.91 CNR1 (0.36) RPS6KB1AKT1AURKBINCENPAURKA
SCHEMBL2986556 0.91 ITGAV (0.35) RPS6KB1AURKAALDH1A1LMNACNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004058743-A1 NOVEL SUBSTITUTED NITROGEN-CONTAINING HETEROBICYCLES AND USE THEREOF AS FACTOR XA INHIBITORS BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2004-07-15 WO disclosed